Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women
NCT05586711
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
170
Enrollment
OTHER
Sponsor class
Conditions
Vulvovaginal Atrophy
Genitourinary Syndrome of Menopause
Interventions
DRUG:
vaginal estradiol 10 μg
DRUG:
vaginal DHEA 6.5 mg
Sponsor
Angelica Lindén Hirschberg